286 related articles for article (PubMed ID: 10519604)
21. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
[TBL] [Abstract][Full Text] [Related]
22. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Zhang L; Weizer JS; Musch DC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
[TBL] [Abstract][Full Text] [Related]
23. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
Best UP; Domack H; Schmidt V
Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
[TBL] [Abstract][Full Text] [Related]
24. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
25. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
26. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
27. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
Sterk CC; Renzenbrink-Bubberman AC; van Best JA
Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
[TBL] [Abstract][Full Text] [Related]
28. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
[TBL] [Abstract][Full Text] [Related]
29. Micropulse diode laser (810 nm) versus argon laser trabeculoplasty in the treatment of open-angle glaucoma: comparative short-term safety and efficacy profile.
Detry-Morel M; Muschart F; Pourjavan S
Bull Soc Belge Ophtalmol; 2008; (308):21-8. PubMed ID: 18700451
[TBL] [Abstract][Full Text] [Related]
30. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
[TBL] [Abstract][Full Text] [Related]
31. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of intraocular pressure elevation after argon laser trabeculoplasty in primary open angle glaucoma].
Bozić M; Hentova-Senćić P; Kontić D; Marković V; Marjanović I
Srp Arh Celok Lek; 2011; 139(1-2):12-7. PubMed ID: 21568077
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.
Barnebey HS; Robin AL; Zimmerman TJ; Morrison JC; Hersh SB; Lewis RA; Coleman AL; Cinotti DJ; Walt J; Chen KS
Ophthalmology; 1993 Jul; 100(7):1083-8. PubMed ID: 8100625
[TBL] [Abstract][Full Text] [Related]
34. [The effect of brimonidine on postoperative hypertonia after an extracapsular cataract extraction].
Katsimpris JM; Petropoulos IK; Voros G; Gerodimos G; Pharmakakis NM
J Fr Ophtalmol; 2003 Apr; 26(4):369-74. PubMed ID: 12843894
[TBL] [Abstract][Full Text] [Related]
35. [Clinical efficacy of 0.2% brimonidine in patients with open-angle glaucoma or ocular hypertension].
Shi JM; Jiang YQ
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):263-6. PubMed ID: 12575311
[TBL] [Abstract][Full Text] [Related]
36. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
37. Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes.
Thomas R; Parikh R; Muliyil J; George R; Paul P; Abraham LM
Indian J Ophthalmol; 2003 Jun; 51(2):123-8. PubMed ID: 12831141
[TBL] [Abstract][Full Text] [Related]
38. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.
Juzych MS; Chopra V; Banitt MR; Hughes BA; Kim C; Goulas MT; Shin DH
Ophthalmology; 2004 Oct; 111(10):1853-9. PubMed ID: 15465546
[TBL] [Abstract][Full Text] [Related]
39. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.
Cullom RD; Schwartz LW
Ophthalmic Surg; 1993 Sep; 24(9):623-6. PubMed ID: 7901828
[TBL] [Abstract][Full Text] [Related]
40. Neodymium:yttrium-aluminum-garnet capsulotomy and intraocular pressure in pseudophakic patients with glaucoma.
Barnes EA; Murdoch IE; Subramaniam S; Cahill A; Kehoe B; Behrend M
Ophthalmology; 2004 Jul; 111(7):1393-7. PubMed ID: 15234143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
